Diaceutics (LON:DXRX) Shares Down 0.6% – Time to Sell?

Diaceutics PLC (LON:DXRX) fell 0.6% during mid-day trading on Thursday . The stock traded as low as GBX 165 and last traded at GBX 166.50. 683,387 shares changed hands during mid-day trading, an increase of 197% from the average session volume of 229,901 shares. The stock had previously closed at GBX 167.50.

Analysts Set New Price Targets

Separately, Shore Capital Group boosted their target price on Diaceutics from GBX 180 to GBX 215 and gave the stock a “buy” rating in a research note on Thursday, January 15th. Three equities research analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, the company presently has an average rating of “Buy” and an average target price of GBX 193.33.

Diaceutics Trading Down 0.6%

The company has a debt-to-equity ratio of 0.39, a quick ratio of 9.92 and a current ratio of 4.85. The company’s 50-day moving average price is GBX 147.80 and its 200-day moving average price is GBX 150.09. The firm has a market capitalization of £140.90 million, a PE ratio of -92.50 and a beta of 0.58.

Diaceutics Company Profile

At Diaceutics we believe that every patient should get the opportunity to receive the right test and the right therapy to positively impact their disease outcome. We provide the world’s leading pharma and biotech companies with an end-to-end commercialisation solution for precision medicines through data analytics, scientific and advisory services enabled by our platform DXRX – The Diagnostics Network®.